Cited by 1,062Immune Response and InflammationImmunotherapy and Immune Responsesinterferon and immune responses

The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.

mRNA Is an Endogenous Ligand for Toll-like Receptor 3

Open access

Karikó, Katalin, Ni, Houping, Capodici, John, Lamphier, Marc, Weissman, Drew·2004·Journal of Biological Chemistry

Open this paper in CoChat — free account

Abstract

Toll-like receptors (TLRs) are the basic signaling receptors of the innate immune system. They are activated by molecules associated with pathogens or injured host cells and tissue. TLR3 has been shown to respond to double stranded (ds) RNA, a replication intermediary for many viruses. Here we present evidence that heterologous RNA released from or associated with necrotic cells or generated by in vitro transcription also stimulates TLR3 and induces immune activation. To assess RNA-mediated TLR3 activation, human embryonic kidney 293 cells stably expressing TLR3 and containing a nuclear factor-kappaB-dependent luciferase reporter were generated. Exposing these cells to in vitro transcribed RNA resulted in a TLR3-dependent induction of luciferase activity and interleukin-8 secretion. Treatment with in vitro transcribed mRNA activated nuclear factor-kappaB via TLR3 through a process that was dose-dependent and involved tyrosine phosphorylation. Furthermore, in vitro transcribed natural or 2'-fluoro-substituted mRNA induced the expression of TLR3, interferon regulatory factor-1, tumor necrosis factor-alpha, and interleukin-1 receptor-associated kinase-M mRNA in human dendritic cells (DCs). DCs responded to mRNA treatment by expressing activation markers, and this maturation was inhibited by antagonistic TLR3-specific antibody. Endogenous RNA released from or associated with necrotic cells also stimulated DCs, leading to interferon-alpha secretion, which could be abolished by pretreatment of necrotic cells with RNase. These results demonstrate that RNA, likely through secondary structure, is a potent host-derived activator of TLR3. This finding has potential physiologic relevance because RNA escaping from damaged tissue or contained within endocytosed cells could serve as an endogenous ligand for TLR3 that induces or otherwise modulates immune responses.

Integrity signals

Registry

Crossref · 10.1074/jbc.m310175200

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information
Zuker, M., & Stiegler, P. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.1.133 · Cited by 3,604
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging
Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,319

Flagged first, then by citations

Show all 63 references

2 of the 63 references couldn’t be matched to a known paper.

Research works printed but not linked: 8

Armant, 2002, Genome Biol.
Barton, 2002, Curr. Top. Microbiol. Immunol., 270, 81
Vabulas, 2002, Curr. Top. Microbiol. Immunol., 270, 169
Grentzmann, 1998, RNA (N. Y.), 4, 479
Williams, 2001, Science's STKE
Kirschning, 2002, Curr. Top. Microbiol. Immunol., 270, 121
Larsson, 2003, Curr. Top. Microbiol. Immunol., 276, 261
Belz, 2002, Crit. Rev. Immunol., 22, 439

Sorted by citations

Items 801–900 of 1,000

Messenger RNA Vaccines
Probst, J., Fotin‐Mleczek, M., Schlake, T., Theß, A., Kramps, T., & Kallen, K. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0439-2_11 · Cited by 7
A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults
Cappelletti–Montano, B., Demuru, G., Laconi, E., & Musio, M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1145645 · Cited by 7
mRNA induces RANTES production in trophoblast cells via TLR3 only when delivered intracellularly using lipid membrane encapsulation
Nakada, E., Nakada, T. A., Walley, K. R., McConechy, M. M., McLaughlin, L., von Dadelszen, P., Shozu, M., & Boyd, J. H. (2011) · Placenta · doi:10.1016/j.placenta.2011.04.011 · Cited by 7
Murine Pancreatic Beta TC3 Cells Show Greater 2′,5′ -Oligoadenylate Synthetase ( 2′5′ AS) Antiviral Enzyme Activity and Apoptosis Following IFN- α or Poly(I:C) Treatment than Pancreatic Alpha TC3 Cells
Li, M., Zheng, D.-J., Field, L. L., & Bonnevie‐Nielsen, V. (2009) · Experimental Diabetes Research · doi:10.1155/2009/631026 · Cited by 7
Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3
Amarante, M. K., Oda, J. M. M., Reiche, E. M. V., Morimoto, H. K., Aoki, M. N., & Watanabe, M. A. E. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.303 · Cited by 7
Next-Generation Therapeutics: mRNA as a Novel Therapeutic Option for Single-Gene Disorders
Michel, T., Wendel, H.-P., & Krajewski, S. (2016) · InTech eBooks · doi:10.5772/62243 · Cited by 7
Innate Immunity
Eckmann, L. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50045-3 · Cited by 6
Inflammation in Wound Repair: Role and Function of Inflammation in Wound Repair
MacLeod, A. S., & Kwock, J. T. (2017) · Wiley eBooks · doi:10.1002/9781119282518.ch14 · Cited by 7
Therapeutic Advances in Peripheral Nerve Injuries: Nerve-Guided Conduit and Beyond
Li, C., Xianyu, M., Li, S., & Wang, C. (2025) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2024.0322 · Cited by 8
Physicochemical and functional assessment of messenger RNA 5′Cap-end impurities under forced degradation conditions
Hutchinson, J., Schweikart, F., Shannon, R., Murthy, A., Bates, S. M., Leone, S., Nissan, T. A., Sideris, D., Lal, C., Button, J., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102570 · Cited by 6
Nanopore-Based Electroporation Enables High-Efficiency, Rapid RNA-Mediated Reprogramming of Primary Fibroblasts into Human iPSCs
Ren, X., Weng, Y., Zhang, Z., Pan, G., Li, C., & Cao, Y. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c01219 · Cited by 6
Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review
Pawar, S., Pingale, P., Garkal, A., Osmani, R. A. M., Gajbhiye, K. R., Kulkarni, M., Pardeshi, K., Mehta, T. A., & Rajput, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131139 · Cited by 6
Recent strategies for enhanced delivery of mRNA to the lungs
Heiser, B. J., Veyssi, A., & Ghosh, D. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2485669 · Cited by 7
Toll in the vessel wall—for better or worse?
Hansson, G. K., & Lundberg, A. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019722108 · Cited by 6
Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature
Hossam, N., Matboli, M., Shehata, H. H., Aboelhussein, M. M., Hassan, M. K., & Eissa, S. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1816136 · Cited by 6
Effect of TLR3/dsRNA complex inhibitor on Poly(I:C)-induced airway inflammation in Swiss albino mice
Arora, S., Gupta, S., Akram, W., Altyar, A. E., & Tagde, P. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-23987-6 · Cited by 7
Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history
Pascolo, S. (2023) · European Journal of Immunology · doi:10.1002/eji.202249941 · Cited by 6
Biomimetic Nanovaccines: A Novel Approach in Immunization
Khojini, J. Y., Babaei, B., Shakarami, M., Mofidi, M., Tahershamsi, Z., Arjmand, T. F., Tajbakhsh, A., & Hayat, S. M. G. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230529094128 · Cited by 6
Necrotic Cells from Head and Neck Carcinomas Release Biomolecules That Are Activating Toll-like Receptor 3
Vasiljević, T., Tarle, M., Hat, K., Lukšić, I., Mikulandra, M., Busson, P., & Glavan, T. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015269 · Cited by 6
Analyses of the 2023 Nobel Prize in Physiology or Medicine: Nucleoside Base Modifications and Effective mRNA Vaccines
Sterner, E. A. (2023) · Science & Technology Libraries · doi:10.1080/0194262x.2023.2292047 · Cited by 6
Expression of toll-like receptors and co-stimulatory molecules in lymphoid tissue during experimental infection of beef calves with bovine viral diarrhea virus of low and high virulence
Palomares, R. A., Parrish, J. E., Woolums, A. R., Brock, K. V., & Hurley, D. J. (2014) · Veterinary Research Communications · doi:10.1007/s11259-014-9613-2 · Cited by 6
Immunology of the Testis and Male Reproductive Tract
Hedger, M. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01112-x · Cited by 6
Decreased RNF41 expression leads to insulin resistance in skeletal muscle of obese women
Breuker, C., Amouzou, C., Fabre, O., Lambert, K., Seyer, P., Bourret, A., Salehzada, T., Mercier, J. G., Sultan, A., & Bisbal, C. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.014 · Cited by 6
Astrocyte-microglia interaction in the expression of a pro-inflammatory or pain-related phenotype: molecular and cellular aspects
Barbierato, M. (2012) · Padua Research Archive (University of Padova) · Cited by 6
The rise of mRNA therapeutic vaccines
Du, J., Fan, Z., Huang, J., Li, Z., Hu, H., & Li, Y. (2025) · RSC Pharmaceutics · doi:10.1039/d4pm00309h · Cited by 5
Pre-Vaccination Immune Profiles and Responsiveness to Innate Stimuli Predict Reactogenicity and Antibody Magnitude Following mRNA Vaccination
Zelkoski, A. E., Goguet, E., Darcey, E. S., Alameh, M., Said, H., Pollett, S. D., Powers, J. H., Laing, E. D., Olsen, C. H., Mitre, E. E. S., et al. (2025) · Vaccines · doi:10.3390/vaccines13070718 · Cited by 5
A potent induction of naked/uridine-unmodified mRNA expression with Jet Injector, Actranza Lab in mouse and rat skins
Terai, K., Kariya, R., Ogata-Aoki, H., Iga, H., Sakamoto, S., Sakano, S., & Okada, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118920 · Cited by 5
Toll-Like Receptor 3 (TLR3) Is Engaged in the Intracellular Survival of the Protozoan Parasite Leishmania (Leishmania) amazonensis
Rath, C. T., Vivarini, Á. D. C., dos Santos, J. V., Medina, J. M., Saliba, A. M., Mottram, J. C., Lima, A. P. C. A., Calegari-Silva, T., Pereira, R. M., & Lopes, U. G. (2022) · Infection and Immunity · doi:10.1128/iai.00324-22 · Cited by 5
Antigenic Recognition by the Brain
Berczi, I. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384691-4.00007-9 · Cited by 5
Differential mRNA expression of Toll‐like receptors and their adaptors in pleural effusions
Chang, L., Hua, C., Chu, C., CHIANG, B., Hung‐Jie, C. H. E. N., & Chung‐Chieh, Y. U. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01614.x · Cited by 5
Priming of cytotoxic T lymphocyte responses by dendritic cells: induction of potent anti-tumor immune responses
Lint, S. V., Nuffel, A. M. T. V., Wilgenhof, S., Benteyn, D., Pen, J. J., Escors, D., Bonehill, A., Neyns, B., Thielemans, K., & Breckpot, K. (2013) · Ghent University Academic Bibliography (Ghent University) · Cited by 5
TLR3 and Inflammatory Skin Diseases: From Environmental Factors to Molecular Opportunities
Tamagawa‐Mineoka, R., Ueta, M., & Katoh, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-43157-4_11 · Cited by 5
Toll-Like Receptors
Martin, D. B., & Gaspari, A. A. (2008) · Springer eBooks · doi:10.1007/978-1-84800-165-7_5 · Cited by 5
Neuroimmune Mechanisms of Cerebellar Development and Its Developmental Disorders: Bidirectional Link Between the Immune System and Nervous System
Eissa, N., Kermarrec, L., & Ghia, J. (2017) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-59749-2_13 · Cited by 5
INFLUENCE OF POLYOXIDONIUM, Poly(I:C), DALARGIN ON THE PROTECTIVE EFFICACY OF YERSINIA PESTIS VACCINE STRAIN EV LINE NIIEG IN EXPERIMENTAL PLAGUE
Shchukovskaya, T. N., Kurylina, A. F., Shavina, N. Y., & Александровна, Б. С. (2020) · Russian Journal of Immunology · doi:10.46235/1028-7221-005-iop · Cited by 5
Cryopreservation alters the immune characteristics of platelets
Wood, B., Padula, M. P., Marks, D. C., & Johnson, L. (2021) · Transfusion · doi:10.1111/trf.16697 · Cited by 5
Inhibitory effects of 2,6-di-O-methyl-α-cyclodextrin on Poly I:C signaling in macrophages
Motoyama, K., Hashimoto, Y., Hirayama, F., Uekama, K., & Arima, H. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.10.003 · Cited by 5
Guardians of neuroimmunity – Toll-like receptors and their RNA ligands
Lehnardt, S., Wallach, T. E., Gres, V., & Henneke, P. (2019) · e-Neuroforum · doi:10.1515/nf-2018-0032 · Cited by 5
Unraveling the potential: mRNA therapeutics in oncology
Gawalski, K., Przybyszewska, W., Hunia, J., Gawalska, A., & Rymarz, A. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1643444 · Cited by 6
Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation
Đerfi, K. V., Vasiljević, T., Dragicevic, T., & Glavan, T. M. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03609-6 · Cited by 4
Distinct innate immune activation profiles of an mRNA-lipid nanoparticle vaccine compared to the empty lipid nanoparticle
Zelkoski, A. E., Mitre, E. E. S., Alameh, M., & Malloy, A. M. W. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.128061 · Cited by 4
Prologue: About DAMPs, PAMPs, and MAMPs
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_11 · Cited by 5
Toll-like receptor 3
Carty, M., & Bowie, A. (2010) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000320802 · Cited by 4
Clinical ophthalmic challenges in the horse: a retrospective view forward
Matthews, A. G. (2014) · Veterinary Ophthalmology · doi:10.1111/vop.12154 · Cited by 4
Combined Stimulation of Nasal Polyp Fibroblasts With Poly IC, Interleukin 4, and Tumor Necrosis Factor α Potently Induces Production of Thymus- and Activation-Regulated Chemokine
Nonaka, M., Ogihara, N., Fukumoto, A., Sakanushi, A., Pawankar, R., & Yagi, T. (2008) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.134.6.630 · Cited by 4
Is There a Role for Immunoregulatory and Antiviral Oligonucleotides Acting in the Extracellular Space? A Review and Hypothesis
Dondalska, A., Pålsson, S. A., & Spetz, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314593 · Cited by 4
Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion
Hirsiger, J. R., Tzankov, A., Alborelli, I., Recher, M., Daikeler, T. D., Parmentier, S. B., & Berger, C. T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1087502 · Cited by 4
Self DNA from Lymphocytes That Have Undergone Activation-Induced Cell Death Enhances Murine B Cell Proliferation and Antibody Production
Lu, Q., Wang, J. O., Wang, L., Jiang, X., & Chu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109095 · Cited by 4
Necrosis: Molecular Mechanisms and Physiological Roles
Duprez, L., Vanlangenakker, N., Festjens, N., Herreweghe, F. V., Berghe, T. V., & Vandenabeele, P. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-381-7_27 · Cited by 4
mRNA Vaccines for Cancer Treatment
Torphy, R. J., Balachandran, V., & Soares, K. C. (2026) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2025.10.006 · Cited by 3
Reactive oxygen species in lipid nanoparticle-based nucleic acid delivery: Mechanisms and engineering
Qiao, P., Yu, J., Li, C., Chen, B., & Wang, Y. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114820 · Cited by 3
mRNA encoding bone morphogenetic protein-2 facilitated peri-implant bone formation of titanium implants placed in rat femurs
Jriyasetapong, K., Lawtrakulngam, N., Vivatbutsiri, P., Namano, S., Wattanasirmkit, K., Angkhanawiriyarak, S., & Suwanwela, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-02931-x · Cited by 3
Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines
Wu, R., Li, H., Li, Z., Hao, K., & Tian, H. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00995b · Cited by 3
Assessment of the Effects of ISIS 2302, an Anti-Sense Inhibitor of Human ICAM-1, on Cellular and Humoral Immunity in Mice
Henry, S. P., Levin, A. A., White, K. L., & Mennear, J. H. (2006) · Journal of Immunotoxicology · doi:10.1080/15476910601046538 · Cited by 3
Poly(I:C) promotes neurotoxic amyloid β accumulation through reduced degradation by decreasing neprilysin protein levels in astrocytes
Yamamoto, N., Tokumon, T., Obuchi, A., Kono, M., Saigo, K., Tanida, M., Ikeda‐Matsuo, Y., & Sobue, K. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15716 · Cited by 5
Hypoxia-inducible Factor-1α Suppresses the Innate Immune Response in Cultured Human Proximal Tubular Cells
Nagawa, D., Shimada, M., Nakata, M., NARITA-KINJO, I., Fujita, T., Murakami, R., Nakamura, N., & Tomita, H. (2023) · In Vivo · doi:10.21873/invivo.13349 · Cited by 3
Other TLR Pathway Defects
de Diego, R. P., & Rodríguez‐Gallego, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00034-0 · Cited by 3
An RNA Sensor Protects against Pulmonary Hypertension
Grünig, G., & Durmuş, N. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1363ed · Cited by 3
The Biology of Toll-Like Receptors and NOD-Like Receptors: The Toggles of Inflammation
Kutikhin, A. G., & Yuzhalin, A. E. (2013) · Springer eBooks · doi:10.1007/978-3-0348-0688-6_1 · Cited by 3
Toll-like receptors and rheumatoid arthritis: is there a connection?
Sacre, S. M., Drexler, S. K., & Foxwell, B. M. J. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7441-1_2 · Cited by 3
Toll-Like Receptors: At the Intersection of Osteoarthritis Pathology and Pain
Wu, Q., & James, L. (2012) · InTech eBooks · doi:10.5772/27504 · Cited by 3
The Significance of Toll-Like Receptors in the Development of Ischemic Damage
Skvortsova, V. I., Shurdumova, M. K., & Константинова, Е. В. (2011) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-011-9453-2 · Cited by 3
Innate Immunity, Toll-Like Receptors, and Diabetes
McInerney, M. F., Alexander, L., Morran, M. P., & Pietropaolo, M. (2009) · Current Immunology Reviews · doi:10.2174/157339509788167038 · Cited by 3
Periostin is critical for improving the therapeutic properties of adipocyte-derived stem cells
Chow, T., & Rogers, I. M. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0215-x · Cited by 3
Innate Immunity and Allograft Rejection
Land, W. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00128-8 · Cited by 3
Double-stranded RNA Induces Inflammatory Gene Expression in Schwann Cells: Implication in the Wallerian Degeneration
Lee, H., Park, C., Choi, S., Oh, S. B., Park, K., Kim, J. S., & Lee, S. J. (2004) · Seoul National University Open Repository (Seoul National University) · Cited by 3
Molecular Mechanism of the Antiproliferative Activity of Short Immunostimulating dsRNA
Zharkov, M. I., Аркадьевна, З. М., Vlassov, V. V., & Chernolovskaya, E. L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01454 · Cited by 3
Microglial Response to Inflammatory Stimuli-Impact of Protein Acetylation and Phosphorylation
Huuskonen, J. (2007) · Cited by 3
Microfluidic platform enables shear-less aerosolization of lipid nanoparticles for messenger RNA inhalationPreprint
Kim, J., Jozić, A., Bloom, E., Jones, B., Marra, M., Murthy, N. T. V., Eygeris, Y., & Sahay, G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.17.576136 · Cited by 3
Cascade amplification of therapeutic payloads for cancer immunotherapy
Li, Y., Wu, J., Li, N., Wu, M., Wang, Z., Li, J., & Zhang, L. (2025) · Communications Biology · doi:10.1038/s42003-025-08735-z · Cited by 2
Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatment
Batho, C. A. P., Hudson, J. E., & Wilson, C. H. (2025) · Biochemical Society Transactions · doi:10.1042/bst20243001 · Cited by 2
Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer
Parikh, C. N., DeMarco, K. D., Bhalerao, N., Giwa, H. K., Kane, G. I., Dinnell, R. W., Ma, B., Mori, H., Brassil, M. L., Murphy, K. C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74574-z · Cited by 3
Design strategies to optimize polymeric vectors for mRNA delivery
Turhan, Z. Y., Savaş, M., Alakbarov, A., & Bulmuş, V. (2025) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2025.2587806 · Cited by 2
Necrotic-cell–activated macrophages drive an ERK–Bcl-xL survival pathway in osteoclasts and confer bisphosphonate resistance
Uehara, K., Katō, K., Tsuji, S., Yukata, K., Takemoto, K., Sakamoto, A., Seto, T., Yamada, Y., Yoshimura, M., Togawa, G., et al. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153591 · Cited by 2
RNA Therapeutics in Viral Infections and Cancer: Mechanisms, Challenges, and Prospects: A Review
Generalov, E. A., Shevelev, A. B., Romanov, D., Tarasova, O. A., & Pozdniakova, N. V. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18040431 · Cited by 3
A comprehensive analysis of the use of nucleoside analogues in RNA therapeutics
Kukushkina-Zvezdova, A. A., Zherebtsova, A. A., Telegina, D. V., Skvortsov, I. A., Ivanov, R. A., & Reshetnikov, V. V. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08083-4 · Cited by 3
Genetic Vaccine for Cancer
Valilou, S. F., & Keshavarz‐Fathi, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814039-0.00010-2 · Cited by 2
COVID-19 and Spanish Flu, the Representative Pandemics of the 21st and 20th Centuries
Shinoda, S. (2022) · Journal of Disaster Research · doi:10.20965/jdr.2022.p0065 · Cited by 3
Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101
Scholz, A., DeFalco, J., Leung, Y., Aydin, I. T., Czupalla, C. J., Cao, W., Santos, D., Vad, N. M., Lippow, S. M., Baía, G. S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123483119 · Cited by 2
Antiviral potential of nanomaterials: Novel solutions for emerging challenges
Azab, W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821637-8.00003-1 · Cited by 2
Toll-like receptor 3 involvement in vascular function
Matsumoto, T., Nagano, T., Taguchi, K., Kobayashi, T., & Tanaka-Totoribe, N. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176842 · Cited by 2
mRNA-based vaccines and therapies - a revolutionary approach for conquering fast-spreading infections and other clinical applications: a review
Pan, M., Cao, W., Zhai, J., Zheng, C., Xu, Y., & Zhang, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143134 · Cited by 2
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer
Oualla, K., Alem, M., & Teoh, J. Y. (2025) · Current Opinion in Urology · doi:10.1097/mou.0000000000001334 · Cited by 2
Role Of Toll Like Receptors In Various Diseases
Güven, B., & Can, M. (2012) · Sakarya Medical Journal · doi:10.5505/sakaryamj.2012.47550 · Cited by 2
mRNA Leapfrogs DNA to Show Promise for Therapeutic Gene Transfer
Gilboa, E. (2012) · Molecular Therapy · doi:10.1038/mt.2012.31 · Cited by 2
Deamination of Adenosines in Extracellular RNA Spontaneously Internalized by Human Cells
Kuligina, E. V., Vratskih, O. V., Semenov, D. V., Матвеева, В. А., & Richter, V. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.036 · Cited by 2
Polly Matzinger's “danger model” finds its predicted danger-denoting self moieties
Palazón, A., Dubrot, J., Martínez‐Forero, I., Rouzaut, A., Ochoa, C., Perez‐Gracia, J. L., Hervás‐Stubbs, S., & Melero, I. (2008) · Inmunología · doi:10.1016/s0213-9626(08)70068-4 · Cited by 2
Toll-like Receptors (TLRs) And Prion Disease: Relevance To Pathology And Novel Therapy
Ofodile, O. (2011) · Cited by 2
Functional Toll-like receptors in primary first trimester trophoblasts
Tangerås, L. H., Stødle, G. S., Olsen, G. D., Leknes, A.-H., Gundersen, A. S., Skei, B., Vikdal, A. J., Ryan, L., Steinkjer, B., Myklebost, M. F., et al. (2013) · Placenta · doi:10.1016/j.placenta.2013.06.099 · Cited by 2
Pathogenesis of Behçet Syndrome
Emmi, G., Squatrito, D., Silvestri, E., Grassi, A., & Emmi, L. (2013) · Rare diseases of the immune system · doi:10.1007/978-88-470-5477-6_6 · Cited by 2
Toll-Like Receptors
Shiu, J., & Gaspari, A. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_2 · Cited by 2
Minor Changes for a Major Impact: A Review of Epigenetic Modifications in Cell-Based Therapies for Stroke
Monsour, M., Gordon, J., Lockard, G., Alayli, A., Elsayed, B., Connolly, J. A., & Borlongan, C. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113106 · Cited by 2
Learning from cancer to address COVID-19
Oláh, E. (2023) · Biologia Futura · doi:10.1007/s42977-023-00156-5 · Cited by 2
Polyinosine-polycytidylic acid promotes excessive iodine intake induced thyroiditis in non-obese diabetic mice via Toll-like receptor 3 mediated inflammation
Ya-nan, S. H. I., Liu, F., Yu, X., Liu, Z., Qing-xin, L., Yuan, J., Xiao-yi, Z., & Li, L. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20122723 · Cited by 2
Abrupt Expression of TLR4 in TLR4-Deficient Macrophages Imposes a Selective Disadvantage: Genetic Evidence for TLR4-Dependent Responses to Endogenous, Nonmicrobial Stimuli
Cohn, E. F., Nathan, C., Radzioch, D., Yu, H. D., Xiang, Z., & Ding, A. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.1185 · Cited by 2
Acides nucléiques microbiens dans la physiopathologie des glomérulonéphrites
Anders, H., Zecher, D., & Schlöndorff, D. (2006) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2006.10.001 · Cited by 2
RNA in the Loop: Probing T-loop/T-loop Receptor Interactions as Mediators of Long-range RNA Contacts that Influence Gene Regulation
Wedekind, J. E. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168087 · Cited by 1
mRNA-Vaccine Platform: Features of Obtaining and Delivery of mRNA
Litvinova, V. R., Рудометов, А. П., Карпенко, Л. И., & Ilyichev, A. A. (2023) · Биоорганическая химия · doi:10.31857/s013234232302015x · Cited by 2
Modern Trends of Pharmacotherapy in PsychoNeuroImmunology
Sarvilina, I. V. (2024) · Integrated science · doi:10.1007/978-3-031-73061-0_24 · Cited by 1
TLR3 regulation and cytokine response during BoAHV-1 and BoAHV-5 infection of neuronal-like cells
Brunner, M. B., Rosales, J. J., Ladera, M., Farías, M. V. N., Verna, A., & Pérez, S. (2025) · Microbes and Infection · doi:10.1016/j.micinf.2025.105558 · Cited by 1

Authors: Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D.
Affiliations: University of Pennsylvania (US)
Eisai (United States) (US)
Corresponding author: Karikó, Katalin
ORCID: Karikó, Katalin
Ni, Houping
Weissman, Drew
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2004-03
Volume: 279
Issue: 13
Pages: 12542-12550
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m310175200
OpenAlex: W1986178107
Cited by: 1,062
References: 63
Citations by year: 2026: 19 · 2025: 41 · 2024: 39 · 2023: 64 · 2022: 48 · 2021: 55 · 2020: 37 · 2019: 32 · 2018: 41 · 2017: 51 · 2016: 38 · 2015: 46 · 2014: 46 · 2013: 57 · 2012: 67
FWCI: 19.76
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 6057 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01hl062060-05)
National Heart, Lung, and Blood Institute (HL62060-04)
National Institute of Allergy and Infectious Diseases (AI-50484, R01AI050484)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords: TLR3, mRNA, endogenous ligands, innate immunity, dendritic cell maturation, necrotic cells, double-stranded RNA, interferon-alpha, NF-κB, tyrosine phosphorylation, IRF1, TNF-α, RNA secondary structure
MeSH terms: Cell Line, Dendritic Cells, Dose-Response Relationship, Drug, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Humans, Ligands, Luciferases, Membrane Glycoproteins, Necrosis, Nucleic Acid Conformation, Plasmids, Protein Kinases, Receptors, Cell Surface, RNA, RNA, Double-Stranded, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Necrosis Factor-alpha, Tyrosine, Blotting, Northern, Signal Transduction, Up-Regulation, Interleukin-8, NF-kappa B, Staurosporine, Genistein, Toll-Like Receptors, Toll-Like Receptor 3, Interleukin-1 Receptor-Associated Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

mRNA Is an Endogenous Ligand for Toll-like Receptor 3

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks